Monopar Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
JANUS HENDERSON GROUP PLC | 05/15/2025 | 1.13 M | $45.60 M | 8.36% | 1.62% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 599.20 K | $21.82 M | 0.00% | 0.86% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 511.21 K | $18.61 M | 0.00% | 0.73% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 168.16 K | $6.12 M | 0.16% | 0.24% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 100.77 K | $3.67 M | -22.50% | 0.14% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 62.00 K | $2.26 M | 100.00% | 0.09% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 60.37 K | $2.20 M | 100.00% | 0.09% |
VANGUARD GROUP INC | 05/09/2025 | 55.23 K | $2.01 M | -2.26% | 0.08% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 48.54 K | $1.77 M | 25.76% | 0.07% |
MARSHALL WACE, LLP | 05/15/2025 | 25.99 K | $946.22 K | 100.00% | 0.04% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 18.48 K | $672.86 K | 100.00% | 0.03% |
STATE STREET CORP | 05/15/2025 | 15.81 K | $575.79 K | 100.00% | 0.02% |
BLACKROCK, INC. | 05/02/2025 | 14.46 K | $526.64 K | 78.55% | 0.02% |
JANE STREET GROUP, LLC | 05/19/2025 | 10.36 K | $377.10 K | 100.00% | 0.01% |
NORTHERN TRUST CORP | 05/13/2025 | 9.16 K | $333.55 K | 100.00% | 0.01% |
OMERS ADMINISTRATION CORP | 05/14/2025 | 9.00 K | $327.69 K | 100.00% | 0.01% |
HRT FINANCIAL LP | 05/15/2025 | 8.23 K | $299.00 K | 100.00% | 0.01% |
UBS GROUP AG | 05/13/2025 | 8.12 K | $295.69 K | 26.44% | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 6.14 K | $223.59 K | 100.00% | 0.01% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 5.91 K | $215.11 K | 0.00% | 0.01% |
GERBER, LLC | 04/23/2025 | 5.60 K | $203.93 K | 100.00% | 0.01% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 2.48 K | $90.22 K | 8,750.00% | 0.00% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 05/15/2025 | 1.76 K | $64.11 K | 100.00% | 0.00% |
MORGAN STANLEY | 05/15/2025 | 1.42 K | $51.85 K | -62.54% | 0.00% |
QUEST PARTNERS LLC | 05/14/2025 | 1.22 K | $44.24 K | 100.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 05/15/2025 | 600 | $21.85 K | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 303 | $11.03 K | -56.47% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 250 | $9.10 K | 0.00% | 0.00% |
CITIGROUP INC | 05/12/2025 | 225 | $8.19 K | 100.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 205 | $7.00 K | 100.00% | 0.00% |
POINT72 (DIFC) LTD | 05/15/2025 | 196 | $7.13 K | 100.00% | 0.00% |
ALLWORTH FINANCIAL LP | 04/30/2025 | 100 | $4.46 K | 100.00% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 100 | $3.64 K | -95.09% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 16 | $583 | 0.00% | 0.00% |
05/02/2025 | 0 | $0 | -100.00% | 0.00% |
Monopar Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Monopar Therapeutics Inc.. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 1.13 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 599,195
RA CAPITAL MANAGEMENT, L.P.: 511,207
Point72 Asset Management, L.P.: 168,160
ADAR1 Capital Management, LLC: 100,774
Affinity Asset Advisors, LLC: 62,000
4.13% of Monopar Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.89 M shares in the last 24 months. This purchase volume represents approximately $104.62 M in transactions.